Genenta is a clinical stage immuno oncology-company
NYC and Milan
Joined September 2014
- Tweets43
- Following12
- Followers280
- Likes66
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET @pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake @SergioAbrignani @niaforg @NucleateHQ @issnaf @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
Genenta Science (NASDAQ:GNTA) retweeted
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET
@pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake
@SergioAbrignani
@niaforg @NucleateHQ @issnaf @assoiotecnews @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
Genenta Science (NASDAQ:GNTA) retweeted
"Strategico avere sperimentazioni cliniche e pre-cliniche in Italia per impatto rilevante sulla vita di tutti noi. Alla base dello sviluppo di una nuova #terapia ci sono le #imprese, grandi ma anche medio-piccole". Il nostro consigliere @pigiparacchi live: bit.ly/42VmfKS
Genenta Science (NASDAQ:GNTA) retweeted
Nucleate welcomes this conversation on connecting international biotech investors and founders in Italy.
We thank our Nucleate Italy and @pigiparacchi for organizing.
xitter.cf/GenentaScience/status/…
Genenta Science (NASDAQ:GNTA) retweeted
Da un'idea alla quotazione in borsa: quella di @GenentaScience è la storia di un vero caso di successo. Al #SIOS23 Summer ci sarà @pigiparacchi, CEO e co-founder di Genenta Science (Nasdaq: $GNTA)
Registrati👉 bit.ly/43c3FPk
Main partner @SACEgroup in collab. @UniLUISS
Genenta Science (NASDAQ:GNTA) retweeted
@GenentaScience $GNTA at #SIOS23 @startup_italia in Rome on 27th @UniLUISS @ProfPrencipe @SACEgroup
@INNOVUPnet @AssobiotecNews @SIMEST_IT @Assolombarda @NaldiniLab @clusteralisei @Cluster_LLS $XBI #biotech
Genenta Science (NASDAQ:GNTA) retweeted
@GenentaScience $GNTA tomorrow with @AssobiotecNews #OneHealth @OdcecMilano
odcec.mi.it/eventi/2023/06/2…
Join the the first fireside chat #InnovitforLifeSciences that brings together the competitiveness of 🇮🇹 Life Sciences 🩺and the experience of 🇺🇸 Investors 🎆
Registration: bit.ly/27June23
@GenentaScience @NIH
Join us for a live session that brings together the competitiveness of Italian Life Sciences and the experience of US Investors.
Innovit for Life Sciences > Road to #JPM24
On Tuesday 27th June 2023 10.30am EDT - 4.30pm CET
@GenentaScience @AssobiotecF
Join us June 22, 7.30pm live at POLIMI – Graduate School of Management with @pigiparacchi CEO @GenentaScience
eventbrite.com/e/biglietti-p…
@GenentaScience is at Sidoti Virtual Event May 10 2023 with our @pigiparacchi CEO and Co-founder , join us
True or False: Cell therapy refers to the transfer of autologous or allogeneic cellular material into a patient for medical purposes
100%True
0%False
4 votes • Final resultsOur lead candidate is a lenti-virus based hematopoietic stem progenitor cell #immunotherapy enabling controlled and targeted interferon-α expression within #cancers. Learn more: bit.ly/3VGjoT3
At Genenta, our scientists bring a unique blend of multi-disciplinary competence, vast experience in #CellTherapy, and a commensurate track-record in the forefront of therapies and #DrugDevelopment. Learn more: bit.ly/40xHqBL
Meet Richard B. Slansky, Chief Financial Officer at Genenta! Richard is a senior financial executive with more than 30 years of experience at various #biopharmaceutical diagnostic and life science companies. Learn more: bit.ly/3ZV3yGf
We're #hiring a new Genenta Science VP Business Development based in New York, New York, United States. Apply today or share this post with your network linkedin.com/feed/update/urn…
Our platform technology triggers the production of alpha-interferon as a therapeutic inside the tumors through a transgene expression control vector, allowing for a robust anti-cancer response with potential minimized systemic toxicity. Check out our MOA: bit.ly/3FXShxs